Michael Scolaro

Michael Scolaro

Sep 01, 2017

Group 6 Copy 130
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Targeted Drug Delivery by using Magnetic Nanoparticles

    What if we could use a novel approach for delivering currently injectable drugs to the body without syringes...

    How does taking Ritalin affect depersonalization-derealization disorder patients?

    We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

    Can low carbohydrate ketogenic diets inhibit cancers?

    Insulin is a hormone which supports growth of normal cells, but also of cancers. A very low carbohydrate...

    Backer Badge Funded